MLL5/KMT2E Antikörper

Produktnummer ABIN6570267

Produktdetails anti-MLL5/KMT2E Antikörper

Target: MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser MLL5/KMT2E Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC), Immunofluorescence (IF)

Aufreinigung: Affinity purification

Immunogen: Recombinant fusion protein of human KMT2E (NP_061152.3).

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC 1:50-1:200 IF 1:50-1:200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3

Konservierungsmittel: Sodium azide

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Avoid freeze / thaw cycles.

Details zu MLL5/KMT2E

Target: MLL5/KMT2E (MLL5) (Myeloid/lymphoid Or Mixed-Lineage Leukemia 5 (Trithorax Homolog) (MLL5))

Andere Bezeichnung: KMT2E (MLL5 Produkte)

Synonyme: HDCMC04P antikoerper, MLL5 antikoerper, 1810033J14Rik antikoerper, 9530077A04Rik antikoerper, D230038D11Rik antikoerper, Mll5 antikoerper, lysine methyltransferase 2E antikoerper, lysine (K)-specific methyltransferase 2E antikoerper, KMT2E antikoerper, Kmt2e antikoerper

Hintergrund: This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a protein with an N-terminal PHD zinc finger and a central SET domain. Overexpression of the protein inhibits cell cycle progression. Alternate transcriptional splice variants have been characterized.

Molekulargewicht:

Observed_MW: 100kDa, 140kDa

Calculated_MW: 68kDa/98kDa/131kDa/180-204kDa

Gen-ID: 55904

UniProt: Q8IZD2

Pathways: Retinoic Acid Receptor Signaling Pathway, Warburg Effekt